
At Novocure, every role contributes to extending the lives of people living with cancer. As our new Senior Manager, Clinical Research Scientist, you’ll play a key part in this mission.
As Senior Manager, Clinical Research Scientist, you will be a scientific and people leader within Global Clinical Development, reporting to the VP Global Clinical Development. You will lead and develop a team of Clinical Research Scientists while providing scientific leadership across multiple clinical development programs evaluating Tumor Treating Fields (TTFields).
This role combines hands-on clinical development expertise with team leadership and significant ownership. You will help drive studies from protocol development through study reporting, establish consistent scientific standards across the CRS organization, and work closely with Clinical Operations, Medical Affairs, Regulatory Affairs, Biostatistics, Data Management, Safety, Clinical Quality Assurance and other cross-functional partners. You will also build strong scientific relationships with investigators, key opinion leaders and study teams to support successful clinical trial execution.
Minimum Requirement:
These additional qualifications are preferred:
This pay range which Novocure expects to pay for this role at the time of this posting is 180,000-220,000 USD. This position may also be eligible for an annual bonus and restricted stock unit grant in addition to a full range of benefits. Individual compensation within this range depends on a variety of factors, including, but not limited to, prior education and experience, job-related knowledge and skills demonstrated.
We offer a flexible, trust-based hybrid working model for most of our office-based roles. Employees are asked to be in the office an average of three days per week, with the flexibility to choose which days’ work best for them. We understand that life is not always predictable, so if you need to adjust your schedule, such as leaving early or starting late occasionally, we trust you to balance your time in a way that works for both you and Novocure.
Novocure is a company with a powerful mission, to extend the lives of people living with some of the most aggressive forms of cancer. Here your work will have a direct impact on patients and those who care about them. Join a team of passionate, collaborative people who support each other, challenge one another, and innovate together. Here, you will connect, grow, and make a real difference. We are a company with the drive of a startup and the strength that comes with 25 years of success.
Novocure operates at a rare crossroad, where advanced medical technology converges with cutting-edge biotechnology. We are the only company to develop and commercialize Tumor Treating Fields (TTFields), a proprietary, groundbreaking therapy designed to disrupt cancer cell division. With us you will find a unique combination of laboratory research work alongside engineering development of advanced technologies. This fusion of disciplines positions us as true pioneers in oncology innovation, leading a new frontier in the treatment of aggressive cancers.
Our patient-forward values
Novocure is an Equal Opportunity Employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sexual orientation, gender identity, age, national origin, disability, protected veteran status or other characteristics protected by federal, state, or local law. We actively seek qualified candidates who are protected veteran and individuals with disabilities as defined under VEVRAA and Section 503 of the Rehabilitation Act.
Novocure is committed to providing an interview process that is inclusive of our applicant’s needs. If you are an individual with a disability and would like to request an accommodation, please email: NovocureRecruitingEEO@novocure.com
If you are excited about this role, please apply.

We are a global oncology company working to extend survival in some of the most aggressive forms of cancer through the development and commercialization of our innovative therapy, Tumor Treating Fields. Our commercialized products are approved in certain countries for the treatment of adult patients with glioblastoma and in the U.S. for the treatment of adult patients with malignant pleural mesothelioma. We have ongoing or completed clinical trials investigating Tumor Treating Fields in brain metastases, non-small cell lung cancer, pancreatic cancer, ovarian cancer, liver cancer and gastric cancer.
Headquartered in Switzerland, Novocure has U.S. operations in Portsmouth, New Hampshire and Chesterbrook, Pennsylvania. Additionally, Novocure has offices in Canada, Germany, Japan, Poland and Israel.